Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
Molecular Cancer Therapeutics|January 24, 2007
Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signalingPeter Mullen, David A Cameron, Max Hasmann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2008
The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patientsChristoph C Zielinski, Ahmad Awada, David A Cameron, et al.
Molecular Endocrinology (Baltimore, Md.)|August 2, 2007
Progressive loss of estrogen receptor alpha cofactor recruitment in endocrine resistanceCatherine Naughton, Kenneth MacLeod, Barbara Kuske, et al.
Molecular Vision|August 4, 2010
Retinal ectopias and mechanically weakened basement membrane in a mouse model of muscle-eye-brain (MEB) disease congenital muscular dystrophyHuaiyu Hu, Joseph Candiello, Peng Zhang, et al.
Pharmacoeconomics|April 21, 2011
Updated cost-effectiveness analysis of trastuzumab for early breast cancer: a UK perspective considering duration of benefit, long-term toxicity and pattern of recurrencePeter S Hall, Claire Hulme, Christopher McCabe, et al.
International Journal of Technology Assessment in Health Care|December 22, 2004
Clinicians' assessments of practice guidelines in oncology: the CAPGO surveyMelissa C Brouwers, Ian D Graham, Steven E Hanna, et al.
The Lancet. Oncology|February 1, 2015
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trialIan H Kunkler, Linda J Williams, Wilma J L Jack, et al.
The New England Journal of Medicine|February 15, 2023
Breast-Conserving Surgery with or without Irradiation in Early Breast CancerIan H Kunkler, Linda J Williams, Wilma J L Jack, et al.
Clinical Breast Cancer|March 21, 2009
A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastasesSusana M Campos, Jean Paul Guastalla, Milayna Subar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2008
Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trialJohn M S Bartlett, Alison Munro, David A Cameron, et al.
Pageof 17